These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34143773)

  • 1. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
    Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
    PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
    Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
    J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid Lineage Ablation of
    Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway.
    Wei G; Liang X; Wu F; Cheng C; Huang S; Zeng Y
    PeerJ; 2024; 12():e17722. PubMed ID: 39006031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovariectomy-induced bone loss in
    Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
    J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
    Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperoside on osteoporosis in ovariectomized mice through estrogen receptor α/ITGβ3 signaling pathway.
    Wei Q; Ouyang M; Guo X; Fu X; Liu T; Luo Y; Tang H; Yang Y; Gao X; Mao H
    Eur J Pharmacol; 2024 Aug; 977():176666. PubMed ID: 38797313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NVP-BHG712 alleviates ovariectomy-induced osteoporosis by modulating osteoclastogenesis.
    Liu X; Liu S; Sun H; Zhang J; Li M; Shi Y; Wang G; Chen W; Cao Y; Lu G; Ning Y; Zhao Y
    Eur J Pharmacol; 2024 Nov; 983():177000. PubMed ID: 39278311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.
    Kim JL; Kim YH; Kang MK; Gong JH; Han SJ; Kang YH
    Biomed Res Int; 2013; 2013():919374. PubMed ID: 23781510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST2 regulates bone loss in a site-dependent and estrogen-dependent manner.
    Macari S; Madeira MFM; Lima ILA; Pereira TSF; Dias GJ; Cirelli JA; de Molon RS; Fukada SY; Szawka RE; Garlet GP; Teixeira MM; Silva TA
    J Cell Biochem; 2018 Nov; 119(10):8511-8521. PubMed ID: 30011081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
    Zhu G; Chen W; Tang CY; McVicar A; Edwards D; Wang J; McConnell M; Yang S; Li Y; Chang Z; Li YP
    Int J Biol Sci; 2022; 18(14):5522-5538. PubMed ID: 36147479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis.
    Xu C; Wei Z; Lv L; Dong X; Xia W; Xing J; Liu H; Zhao X; Liu Y; Wang W; Jiang H; Gong Y; Liu C; Xu K; Wang S; Akimoto Y; Hu Z
    Biochem Biophys Res Commun; 2024 Oct; 727():150317. PubMed ID: 38959733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
    Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
    Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
    J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.